Investor Center

• Press Releases
• Events & Presentations
• Corporate Governance
  • Management
  • Board of Directors
  • Committee Composition
  • Contact the Board
  • Insider Transactions
  • Director & Officer Ownership
• Financial Information
  • SEC Filings
  • Annual Reports
  • Quarterly Results
  • Key Ratios
• Stock Information
  • Historic Stock Lookup
  • Investment Calculator
  • Analyst Coverage
  • Ownership Profile
• Investor FAQs
• Contact Us

     

Management

show all hide all

DeVivo, Joe

President and Chief Executive Officer

President and Chief Executive Officer Joseph DeVivo joined AngioDynamics in September 2011, bringing with him the track record and leadership expertise to help AngioDynamics capitalize on its full potential. Previously, Mr. DeVivo was CEO and President of RITA Medical Systems where he transitioned it from an ablation company to the leader in medical device oncology. AngioDynamics acquired RITA in 2006, and its products formed much of AngioDynamics' Oncology/Surgery division, which has been a key driver of the Company's growth. Mr. DeVivo most recently served as Global President of Smith & Nephew Orthopedics, where he successfully led its $2 billion global orthopedics business to record growth. Prior to RITA Medical Systems, Mr. DeVivo served as President, Chief Operating Officer and Director of Computer Motion Incorporation (CMI), leading a turnaround and successful merger with Intuitive Surgical, Inc. Mr. DeVivo previously served as Vice President and General Manager of a $350 million division of TYCO International's Healthcare Business, U.S. Surgical/Davis and Geck Sutures, where he was responsible for sales, marketing, research and development, and finance in its vascular business. During his nine-year tenure at U.S. Surgical, he held various management positions related to sales and marketing, supervising numerous product launches and implementing new sales and marketing strategies. Mr. DeVivo earned his Bachelor of Science degree in Business Administration from the E. Clairborne Robins School of Business at the University of Richmond.

Gersuk, Joseph

Executive Vice President, Chief Financial Officer

Executive Vice President & Chief Financial Officer D. Joseph Gersuk is responsible for overseeing all financial operations, directing financial strategy and providing strategic input and leadership on opportunities for Company growth. Mr. Gersuk has more than 25 years of experience as a senior financial executive, having served as CFO of emerging technology companies, including publicly traded MapInfo Corporation, DataEase Sapphire International and Staveley NDT Technologies. His background includes financial expertise in mergers and acquisitions, working capital management, treasury, regulatory accounting and reporting, and implementation of strong internal controls. Mr. Gersuk holds an M.B.A., finance from American University and a B.S. from the United State Naval Academy. He is an active community leader, currently serving as trustee and chairman of the board for Ellis Hospital in Schenectady, N.Y., and previously as trustee and treasurer of the Albany Academy for Girls. Mr. Gersuk also served as Director and audit committee Chair for American Bio Medica Corporation from 2002-03.

Etlinger, Scott

Senior Vice President, Global Operations

Senior Vice President of Global Operations, Scott Etlinger joined AngioDynamics in August 2010 bringing with him necessary leadership and global experience to implement operational strategies required to achieve the Company's growth and profitability objectives. Mr. Etlinger's principal responsibilities are manufacturing, sourcing and global supply chain management. Prior to joining AngioDynamics, Mr. Etlinger previously served as Chief Operating Officer of Dental Services Group, a leading dental services and manufacturing company. Prior to that, he was the Senior Vice President of Global Operations and a member of the senior leadership team at American Medical Systems. Mr. Etlinger also was previously with Zimmer (formerly Centerpulse Orthopedics), a leader in orthopedic implants, for a decade, starting as Global Financial Controller before rising to Vice President, Global Supply Chain. He earned his MBA from St. Edwards University in Austin, Texas.

Haire, Donna

Senior Vice President of Regulatory, Quality, Clinical and Medical Affairs

Senior Vice President of Regulatory, Quality, Clinical and Medical Affairs Donna Haire joined AngioDynamics in November 2011 bringing with her a proven record as a turn-around leader. Ms. Haire most recently served as Senior Director of Quality, Regulatory and Sustainability at Philips Healthcare subsidiary Global Diagnostic X-Ray, where she increased compliance and strengthened accountability by driving culture change and the redesign of the Quality Management System. She was also the Imaging Systems Corporate Director of Regulatory, Quality, Clinical and Standards for Philips Healthcare for 21 sites world-wide, successfully creating and executing global regulatory and clinical strategies. Prior to Philips, Ms. Haire was Director of Regulatory Affairs, Technical Communications and Compliance Engineering at Medtronic Emergency Response Systems. Previously, she held leadership positions at Avery Dennison Medical and STERIS Corporation. Ms. Haire earned a B.S. in Biology/Physiology/Pre-Med from The University of Akron and her M.S. in Biology from Cleveland State University.

Kapusta, Matthew

Senior Vice President of Business Development

Senior Vice President of Business Development Matthew Kapusta joined AngioDynamics in November 2011 as a seasoned executive who has advised on more than 50 transactions valued at over $6 billion. While most recently serving as Vice President of Strategic Planning and Financial Analysis for Smith & Nephew Orthopaedics, he formed the Business Intelligence and Analytics team responsible for developing data-driven insights and understanding business performance. Mr. Kapusta also spearheaded strategic and financial planning for Smith & Nephew's global Hips, Knees and Trauma franchises. Prior to Smith & Nephew, Mr. Kapusta was a Managing Director of Healthcare Investment Banking at Collins Stewart in New York City. He also previously served as Vice President of Healthcare Mergers and Acquisitions at Wells Fargo Securities, and had similar roles at Robertson Stephens and PaineWebber. Mr. Kapusta earned a BBA in Finance, Accounting, from the University of Michigan and has an MBA in Finance, Business Management, from New York University.

McGill, Stephen

Senior Vice President and General Manager, International

Senior Vice President and General Manager, International, Stephen McGill joined AngioDynamics in November 2009. Based in Europe, Mr. McGill is using his in-depth knowledge of the global healthcare industry to lead AngioDynamics' expansion of its international business. Mr. McGill previously served as a Principal at AEM Global, a consulting firm specializing in developing market opportunities worldwide for medical device companies. He worked at American Medical Systems for eight years, most recently serving as Senior Vice President, Global Sales. Mr. McGill has also held leadership roles with Bolton Medical, Boston Scientific, Stryker UK, Wesley Jessen (a division of Schering Plough) and Allergen. He attended Anniesland College in Glasgow.

Panzer, Alan

Senior Vice President and General Manager, Vascular

Senior Vice President and General Manager, Vascular, Alan Panzer joined AngioDynamics in September 2011 bringing with him more than 20 years of industry experience, including broad executive leadership at multiple surgical device and vascular organizations. Mr. Panzer most recently served as President & CEO of DeVilbiss Healthcare, where he successfully executed the challenging refocusing of the organization, leading to a turnaround of the company and profitability. Prior to DeVilbiss, Mr. Panzer was President of United States Surgical & Valleylab, now a business unit of Covidien, where annual revenue grew from $550 million to $1.2 billion during his tenure. He also has served as a member of the Multiple Myeloma Research Foundation Board. Mr. Panzer earned his Bachelor of Science in Pharmacy from St. John's University in New York.